Metabolic Tumor Volume Measured by 18 F-FDG PET/CT is Associated with the Survival of Unresectable Hepatocellular Carcinoma Treated with PD-1/PD-L1 Inhibitors Plus Molecular Targeted Agents.

Xuezhu WangXu YangJingnan WangChengyan DongJie DingMeiqi WuYanyu WangHaiyan DingHui ZhangXin-Ting SangHaitao ZhaoLi Huo

Published in: Journal of hepatocellular carcinoma (2023)

High MTV is an adverse prognostic factor in patients with uHCC treated with a combination of immunotherapy and molecular targeted agents. Integrating PET/CT parameters with clinical prognostic factors could help to personalize immunotherapy.

Keyphrases

prognostic factors
pet ct
cancer therapy
positron emission tomography
single molecule
locally advanced
emergency department
squamous cell carcinoma
adverse drug
drug induced